Molgramostim Nebulizer Solution Expanded Access Program Protocol
- Status
- AVAILABLE
- Phase
- N/A
Clinical Trials Related to Autoimmune Pulmonary Alveolar Proteinosis
Related studies linked through entity extraction aliases.
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
- Status
- RECRUITING
- Phase
- PHASE3
Study of Human Bone Marrow Mesenchymal Stem Cells in APAP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- N/A
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
- Status
- TERMINATED
- Phase
- PHASE3
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
- Status
- COMPLETED
- Phase
- PHASE2
Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
- Status
- UNKNOWN
- Phase
- PHASE2
Inhaled GM-CSF Therapy of Autoimmune PAP
- Status
- COMPLETED
- Phase
- PHASE2